Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Med Arch. 2015; 69(6): 393-395


Buscopan Application as an Analgesic in Primiparas

Mohammad Abou El-Ardat, Fatima Gavrankapetanovic, Sanjin Dekovic, Mirza Kozaric, Mirna Rakocevic, Khalil A. Abou El-Ardat, and Lejla Zunic.




Abstract

Introduction: Scopolamine butylbromide or Buscopan is a drug that belongs to a group spasmolytic agents. Its clinical application it is found during childbirth, especially during the first stage of labor. It has a direct effect on the smooth muscles of the pelvis and a small cervical-uterine plexus. The study is conducted at the Clinic of Obstetrics and Gynecology of the University Clinical Centre in Sarajevo and included 100 primiparas. The respondents were divided into two groups. To the test group is administered Buscopan 40mg in 500ml of saline, during the first stage of labor and dilatation of 4-5 cm. The control group did not receive Buscopan. Results: Conducted is a comparative analysis where it was found that among the respondents of the test group, the time of active labor reduced to about 1 hour and 45 minutes. On a scale of pain intensity, decrease started after 10 minutes following the Buscopan application. Apgar score did not differ significantly. But the pain decreased in 54.54% of primiparas in the test group. On the basis of this study and according to the results we can come to the conclusion that the effectiveness of Buscopan as analgesics during childbirth in primiparas is very good. Conclusion: The clinical application of the Buscopan is justified in obstetric practice in order to reduce the pain, especially in primiparas.

Key words: Buscopan, analgesic, primiparas.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.